Document Detail


Economic evaluation of the decisions of the Israeli Public Committee for updating the National List of Health Services in 2006/2007.
MedLine Citation:
PMID:  18657095     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The Public Committee (PC), which decides on the inclusion and ranking of new technologies in the Israeli List of Health Services facing a given budget, does not explicitly consider the results of economic evaluations of the technologies discussed. The present article includes an ex post economic examination of the PC's 2006/2007 decisions. METHODS: The cost per quality-adjusted life-year (QALY) (CPQ) values of the technologies approved and rejected were retrieved from national health technologies assessments and the professional literature. RESULTS: CPQ values were found for 40 technologies out of the 52 that were approved by the PC, and for 26 out of 42 randomly sampled among those rejected. The technologies approved for inclusion produce QALYs in a cheaper way, in general, than those rejected. A CPQ of about 50,000 new Israeli shekels (NIS) (15,500 USDPPP [purchasing power parity adjusted U.S. dollars]) is identified as the best discriminating value between approved and rejected technologies. The agreement between the PC's ranking of the approved technologies and the ranking by CPQ is low, and the only significant determinant of the Committee's ranking is the number of patients expected to benefit from the technology. CONCLUSIONS: Although not considering CPQ data explicitly, the PC tends, in fact, to approve technologies with relatively low CPQ. In ranking the approved technologies, however, the PC tries to maximize the number of persons expected to benefit from the additional budget even at the expense of possibly giving up cheaper QALYs. The size of the budget should be determined in accordance with an Israeli value of QALY and Israeli values of the CPQ of the technologies submitted for inclusion.
Authors:
Amir Shmueli
Related Documents :
15502705 - Public consultation on xenotransplantation.
19944935 - Leveraging neighborhood-scale change for policy and program reform in buffalo, new york.
19126245 - Assessing the impact of england's national health service r&d health technology assessm...
21063555 - Obstetric medical emergency teams are a step forward in maternal safety!
23489035 - Capacity building in anthelmintic drug discovery.
2586315 - Public opinion, public policy, and hiv infection.
Publication Detail:
Type:  Journal Article     Date:  2008-07-24
Journal Detail:
Title:  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research     Volume:  12     ISSN:  1524-4733     ISO Abbreviation:  Value Health     Publication Date:    2009 Mar-Apr
Date Detail:
Created Date:  2010-07-29     Completed Date:  2010-09-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883818     Medline TA:  Value Health     Country:  United States    
Other Details:
Languages:  eng     Pagination:  202-6     Citation Subset:  IM    
Affiliation:
The Hebrew University and the Gertner Institute, Jerusalem, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Advisory Committees / economics*,  organization & administration
Decision Making, Organizational*
Humans
Israel
National Health Programs / economics*,  organization & administration
Quality of Life
Quality-Adjusted Life Years*
ROC Curve
Statistics as Topic
Statistics, Nonparametric
Technology Assessment, Biomedical / economics,  organization & administration

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cross-Cultural Validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial Questionnai...
Next Document:  Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 Preference-Based SF-6D in ...